Douglas Monieson - CME Independent Director

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 40px;;'>CME</div>
CME -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Mr. Douglas M. Monieson is an Independent Director of the Company. Mr. Monieson was a member and active futures trader on CME for 25 years. He is a member of CME, CBOT, NYMEX and COMEX. He serves on our political action and pit supervision committees. Mr. Monieson is a founding member of the NASDAQ 100 pit and served as the pit vicechairman from 19972001. Mr. Monieson is an active fintech angel investor and Chairman Emeritus and board member of Hyde Park Angels, a leading Chicagobased angel investment group. Mr. Monieson has extensive board experience in nominating, compensation and audit and serves on the board of several venture backed companies. Through Hyde Park Angels, he has worked with CME Ventures, the CME Group Foundation and the Futures Industry Association to identify and showcase new and disruptive technology affecting our industry
Age: 50  Director Since 2016      
312-930-1000  http://www.cmegroup.com
Monieson serves on the Advisory Board of the University of Chicago Polksy Center for Entrepreneurship and on the Advisory Board of Top Step Trader, a Chicago based firm that is identifying new futures traders and bringing retail business to CME.

Management Efficiency

The company has Return on Asset of 2.12 % which means that on every $100 spent on asset it made $2.12 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 8.12 % implying that it generated $8.12 on every 100 dollars invested.
The company has 3.74 B in debt with debt to equity (D/E) ratio of 14.3 . This implies that the company may be unable to create cash to meet all of its financial commitments. CME Group has Current Ratio of 1.01 demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Nozipho JanuaryBardillAngloGold Ashanti Limited
David HodgsonAngloGold Ashanti Limited
Steven KaplanMorningstar
David RosatoNasdaq
Rodolphe ValleeMSCI
Scott BilleadeauFactSet Research Systems
Leslie SeidmanMoodys Corporation
Gilles MassonSEMAFO INC
Terence BowlesSEMAFO INC
Laurie SiegelFactSet Research Systems
Duriya FarooquiIntercontinental Exchange
Tertius ZongoSEMAFO INC
Alfred ZollarNasdaq
Jacob WallenbergNasdaq
Rodney RustonAngloGold Ashanti Limited
Robert HaleMSCI
Linda RieflerMSCI
Thomas KloetNasdaq
Lumkile NkuhluAngloGold Ashanti Limited
Scott MillerFactSet Research Systems
Robert AsheMSCI

Company Summary

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in USA and is traded on BATS Exchange.CME Group (CME) is traded on BATS Exchange in USA. It is located in 20 South Wacker Drive and employs 4,590 people. CME Group was previously known as Cme Group and was traded on BATS Exchange under the symbol MX4A. CME is listed under Trading category by Fama And French industry classification.

CME Group Leadership Team

Ana Dutra, Independent DirectorView
Daniel Glickman, Independent DirectorView
Howard Siegel, Independent DirectorView
Kathleen Cronin, Senior Managing Director, General Counsel, Corporate SecretaryView
Dennis Chookaszian, Independent DirectorView
Steven Wollack, Independent DirectorView
William Miller, Independent DirectorView
Derek Sammann, Senior Managing Director - Financial Products and ServicesView
Cees Vermaas, Managing Director & CEO of CME Europe LimitedView
Gedon Hertshten, Independent DirectorView
Elizabeth Cook, Independent TrusteeView
Daniel Kaye, DirectorView
Douglas Monieson, Independent DirectorView
William Knottenbelt, Senior Managing Director, Europe, Middle East, Africa (EMEA)View
John Pietrowhicz, Senior Managing Director - Business Development and Corporate FinanceView
Jeffrey Bernacchi, Independent DirectorView
James Oliff, Independent DirectorView
Sunil Cutinho, President - CME ClearingView
Julie Holzrichter, COO and Sr. Managing DirectorView
Timothy Bitsberger, Independent DirectorView
Bryan Durkin, Chief Commercial Officer and Sr. Managing DirectorView
Patrick Maloney, Independent DirectorView
Dennis Suskind, Independent DirectorView
Alex Pollock, Lead Independent DirectorView
Leo Melamed, Chairman EmeritusView
Charles Carey, Vice Chairman of the BoardView
Hilda Piell, Chief Human Resource Officer, Senior Managing DirectorView
Kimberly Taylor, President of Global Operations, Technology and RiskView
David Wescott, Independent DirectorView
Edemir Pinto, Independent DirectorView
Deborah Lucas, Independent DirectorView
John Sandner, DirectorView
Jack Tobin, Chief Accounting Officer, Managing DirectorView
Larry Gerdes, Independent DirectorView
Phupinder Gill, CEO, Director, Member of Competitive Markets Advisory Council, Member of Executive Committee and Member of Strategic Steering CommitteeView
Linda Rich, Senior Managing Director - Government Relations and Legislative AffairsView
Terry Savage, Independent DirectorView
Bruce Johnson, Independent DirectorView
Julie Winkler, Senior Managing Director - Research and Product DevelopmentView
Ronald Pankau, Independent DirectorView
Kevin Kometer, CIO, Senior Managing DirectorView
Robert Zagotta, Senior Managing Director - Products and ServicesView
Yra Harris, DirectorView
Terrence Duffy, Executive Chairman and President Member of Competitive Markets Advisory Council, Chairman of Executive Committee and Member of Strategic Steering CommitteeView
Michael Spencer, DirectorView
Martin Gepsman, Independent DirectorView
William Hobert, Independent TrusteeView
Sean Tully, Senior Managing Director - Interest Rates, OTC ProductsView
William Shepard, Independent DirectorView

Stock Performance Indicators

Current Sentiment - CME

CME Group Investor Sentiment

Greater number of Macroaxis users are currently bullish on CME Group. What is your opinion about investing in CME Group? Are you bullish or bearish?
98% Bullish
2% Bearish

CME Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for CME and SEMAFO INC. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.